Filing Details
- Accession Number:
- 0001213900-23-048683
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-06-13 20:54:21
- Reporting Period:
- 2023-06-13
- Accepted Time:
- 2023-06-13 20:54:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1788028 | Jasper Therapeutics Inc. | JSPR | Biological Products, (No Disgnostic Substances) (2836) | 842984849 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1882877 | Singh Jeetinder Mahal | C/O Jasper Therapeutics, Inc. 2200 Bridge Parkway, Suite 102 Redwood City CA 94065 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Voting Common Stock | Acquisiton | 2023-06-13 | 9,000 | $0.71 | 296,223 | No | 4 | M | Direct | |
| Voting Common Stock | Disposition | 2023-06-13 | 9,000 | $1.66 | 287,223 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Voting Common Stock | Stock Option (right to buy) | Acquisiton | 2023-06-13 | 9,000 | $0.00 | 9,000 | $0.71 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 173,713 | 2030-05-31 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2023.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.62 to $1.69, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
- 25% of the original number of shares subject to the option vested on December 12, 2020, and 1/48th of the original number of shares have vested and shall vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date.
Billionaire Hedge Funds
